Identification of c-MYC as a target of the APC pathway.

The adenomatous polyposis coli gene (APC) is a tumor suppressor gene that is inactivated in most colorectal cancers. Mutations of APC cause aberrant accumulation of beta-catenin, which then binds T cell factor-4 (Tcf-4), causing increased transcriptional activation of unknown genes. Here, the c-MYC oncogene is identified as a target gene in this signaling pathway. Expression of c-MYC was shown to be repressed by wild-type APC and activated by beta-catenin, and these effects were mediated through Tcf-4 binding sites in the c-MYC promoter. These results provide a molecular framework for understanding the previously enigmatic overexpression of c-MYC in colorectal cancers.

[1]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Groudine,et al.  Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line , 1982, Nature.

[3]  M. Erisman,et al.  Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene , 1985, Molecular and cellular biology.

[4]  K. Sikora,et al.  c‐myc oncogene expression in colorectal cancer , 1987, Cancer.

[5]  J. K. Scott,et al.  The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. , 1988, Oncogene.

[6]  K. Isono,et al.  Expression of c‐myc oncogene in colorectal polyps as a biological marker for monitoring malignant potential , 1989, Cancer.

[7]  R Grosschedl,et al.  DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. , 1991, Genes & development.

[8]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[9]  H. Clevers,et al.  Identification and cloning of TCF‐1, a T lymphocyte‐specific transcription factor containing a sequence‐specific HMG box. , 1991, The EMBO journal.

[10]  C. Dang,et al.  Function of the c‐Myc oncoprotein , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  S. Astrin,et al.  Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Patel,et al.  myc function and regulation. , 1992, Annual review of biochemistry.

[13]  D. Smith,et al.  Over-expression of the c-myc proto-oncogene in colorectal carcinoma. , 1993, British Journal of Cancer.

[14]  F. Masiarz,et al.  Association of the APC gene product with beta-catenin. , 1993, Science.

[15]  K. Kinzler,et al.  Deletion of p16 and p15 genes in brain tumors. , 1994, Cancer research.

[16]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[17]  T. Pollard,et al.  Wild-type but not mutant APC associates with the microtubule cytoskeleton. , 1994, Cancer research.

[18]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[19]  P. Polakis,et al.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[21]  K. Kinzler,et al.  Apoptosis and APC in colorectal tumorigenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[23]  M. Esumi,et al.  Activation but not inactivation of the MTS1 gene is associated with primary colorectal carcinomas. , 1996, Biochemical and biophysical research communications.

[24]  W. Kaelin,et al.  Role of the retinoblastoma protein in the pathogenesis of human cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[26]  B. Amati,et al.  Cyclin E and c‐Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins , 1997, The EMBO journal.

[27]  Paul Polakis,et al.  Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.

[28]  Hans Clevers,et al.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 , 1998, Nature Genetics.